Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M
allosteric ligands
modulators
muscarinic acetylcholine receptor
Journal
ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013
Informations de publication
Date de publication:
08 01 2021
08 01 2021
Historique:
received:
21
07
2020
pubmed:
28
8
2020
medline:
18
9
2021
entrez:
28
8
2020
Statut:
ppublish
Résumé
This study investigated the structure-activity relationships of 4-phenylpyridin-2-one and 6-phenylpyrimidin-4-one M
Identifiants
pubmed: 32851779
doi: 10.1002/cmdc.202000540
doi:
Substances chimiques
4-phenylpyridin-2-one
0
Pyridones
0
Receptor, Muscarinic M1
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
216-233Subventions
Organisme : Wellcome Trust
ID : 201529Z16Z
Pays : United Kingdom
Informations de copyright
© 2020 Wiley-VCH GmbH.
Références
M. P. Caulfield, N. J. M. Birdsall, Pharmacol. Rev. 1998, 50, 279-290.
R. M. Eglen, Prog. Med. Chem. 2005, 43, 105-136;
R. M. Eglen, Auton. Autacoid Pharmacol. 2006, 26, 219-233;
J. Wess, Muscarinic Acetylcholine Receptors, Vol. 1, Wiley, 2007, pp. 147-192.
M. P. Caulfield, Pharmacol. Ther. 1993, 58, 319-379;
N. M. Nathanson, Proc. Natl. Acad. Sci. USA 2000, 97, 6245-6247.
J. Wess, Annu.Rev. Pharmacol. Toxicol. 2004, 44, 423-450.
A. Schiavone, A. Sagrada, R. Micheletti, A. Giachetti, Br. J. Pharmacol. 1988, 94, 566-572.
O. Soukup, M. Winder, U. K. Killi, V. Wsol, D. Jun, K. Kuca, G. Tobin, Curr. Neuropharmacol. 2017, 15, 637-653.
“Cholinesterase Inhibitors for Alzheimer's Disease”, J. Birks, Cochrane Database Syst. Rev., 2006, p. CD005593;
J. Wess, R. M. Eglen, D. Gautam, Nat. Rev. Drug Discovery 2007, 6, 721-733;
D. M. Thal, B. Sun, D. Feng, V. Nawaratne, K. Leach, C. C. Felder, M. G. Bures, D. A. Evans, W. I. Weis, P. Bachhawat, T. S. Kobilka, P. M. Sexton, B. K. Kobilka, A. Christopoulos, Nature 2016, 531, 335-340.
A. Christopoulos, Nat. Rev. Drug Discovery 2002, 1, 198-210;
P. J. Conn, C. W. Lindsley, J. Meiler, C. M. Niswender, Nat. Rev. Drug Discovery 2014, 13, 692-708;
M. Decker, U. Holzgrabe, MedChemComm 2012, 3, 752-762;
P. J. Conn, A. Christopoulos, C. W. Lindsley, Nat. Rev. Drug Discovery 2009, 8, 41-54.
L. Ma, M. Seager, M. Wittmann, M. Jacobson, D. Bickel, M. Burno, K. Jones, V. K. Graufelds, G. Xu, M. Pearson, A. McCampbell, R. Gaspar, P. Shughrue, A. Danziger, C. Regan, R. Flick, D. Pascarella, S. Garson, S. Doran, C. Kreatsoulas, L. Veng, C. W. Lindsley, W. Shipe, S. Kuduk, C. Sur, G. Kinney, G. R. Seabrook, W. J. Ray, Proc. Natl. Acad. Sci. USA 2009, 106, 15950-15955, S15950/15951-S15950/15959.
S. N. Mistry, M. Jörg, H. Lim, N. B. Vinh, P. M. Sexton, B. Capuano, A. Christopoulos, J. R. Lane, P. J. Scammells, J. Med. Chem. 2016, 59, 388-409;
S. N. Mistry, H. Lim, M. Jörg, B. Capuano, A. Christopoulos, J. R. Lane, P. J. Scammells, ACS Chem. Neurosci. 2016, 7, 647-661;
J. C. C. Dallagnol, E. Khajehali, E. T. van der Westhuizen, M. Jörg, C. Valant, A. G. Gonçalves, B. Capuano, A. Christopoulos, P. J. Scammells, J. Med. Chem. 2018, 61, 2875-2894;
A. Abdul-Ridha, J. R. Lane, S. N. Mistry, L. López, P. M. Sexton, P. J. Scammells, A. Christopoulos, M. Canals, J. Biol. Chem. 2014;
A. Abdul-Ridha, L. Lopez, P. Keov, D. M. Thal, S. N. Mistry, P. M. Sexton, J. R. Lane, M. Canals, A. Christopoulos, J. Biol. Chem. 2014, 289, 6067-6079;
S. N. Mistry, C. Valant, P. M. Sexton, B. Capuano, A. Christopoulos, P. J. Scammells, J. Med. Chem. 2013, 56, 5151-5172;
M. A. Brodney, J. E. Davoren, M. R. Garnsey, L. Zhang, S. V. O′Neil, Preparation of Pyridine-2-carboxamide Derivatives as Muscarinic M1 Receptor Positive Allosteric Modulators, Pfizer, USA . 2016, p. 174pp;
J. E. Davoren, M. Garnsey, B. Pettersen, M. A. Brodney, J. R. Edgerton, J.-P. Fortin, S. Grimwood, A. R. Harris, S. Jenkinson, T. Kenakin, J. T. Lazzaro, C.-W. Lee, S. M. Lotarski, L. Nottebaum, S. V. O′Neil, M. Popiolek, S. Ramsey, S. J. Steyn, C. A. Thorn, L. Zhang, D. Webb, J. Med. Chem. 2017, 60, 6649-6663;
J. E. Davoren, C.-W. Lee, M. Garnsey, M. A. Brodney, J. Cordes, K. Dlugolenski, J. R. Edgerton, A. R. Harris, C. J. Helal, S. Jenkinson, G. W. Kauffman, T. P. Kenakin, J. T. Lazzaro, S. M. Lotarski, Y. Mao, D. M. Nason, C. Northcott, L. Nottebaum, S. V. O′Neil, B. Pettersen, M. Popiolek, V. Reinhart, R. Salomon-Ferrer, S. J. Steyn, D. Webb, L. Zhang, S. Grimwood, J. Med. Chem. 2016, 59, 6313-6328;
J. M. Rook, M. Abe, H. P. Cho, K. D. Nance, V. B. Luscombe, J. J. Adams, J. W. Dickerson, D. H. Remke, P. M. Garcia-Barrantes, D. W. Engers, J. L. Engers, S. Chang, J. J. Foster, A. L. Blobaum, C. M. Niswender, C. K. Jones, P. J. Conn, C. W. Lindsley, ACS Chem. Neurosci. 2017, 8, 866-883;
J. D. Panarese, H. P. Cho, J. J. Adams, K. D. Nance, P. M. Garcia-Barrantes, S. Chang, R. D. Morrison, A. L. Blobaum, C. M. Niswender, S. R. Stauffer, P. J. Conn, C. W. Lindsley, Bioorg. Med. Chem. Lett. 2016, 26, 3822-3825;
C. W. Lindsley, P. J. Conn, S. R. Stauffer, J. D. Panarese, Substituted 1-Benzylquinoxalin-2(1H)-one Analogs as Positive Allosteric Modulators of Muscarinic Acetylcholine Receptor M1, Vanderbilt University, USA. 2014, p. 208pp;
C. W. Lindsley, P. J. Conn, S. R. Stauffer, J. D. Panarese, Quinazolinone and Pyridopyrimidinone Derivatives as Positive Allosteric Modulators of Muscarinic Acetylcholine Receptor M1 and Their Preparation and Use for the Treatment of Neurological and Psychiatric Disorders, Vanderbilt University, USA. 2014, p. 225;
C. W. Lindsley, P. J. Conn, D. W. Engers, K. A. Bollinger, J. L. Engers, Preparation of Substituted Thienopyridine, Pyrrolopyridine and Pyrazolopyridine Analogs as Positive Allosteric Modulators of Muscarinic Acetylcholine Receptor M1, Vanderbilt University, USA . 2017, p. 184;
B. J. Melancon, J. C. Tarr, J. D. Panarese, M. R. Wood, C. W. Lindsley, Drug Discovery Today 2013, 18, https://doi.org/10.1016/j.drudis.2013.09.005.
R. V. Pustovit, M. Ringuet, S. Diwakarla, X.-Y. Chai, R. M. McQuade, J. B. Furness, R. V. Pustovit, M. Ringuet, S. Diwakarla, X.-Y. Chai, R. M. McQuade, J. B. Furness, Y. Itomi, Y. Tsukimi, Neurogenetics 2019, 31, e13692;
S. Sasaki, Y. Asano, H. Maezaki, A. Sato, Preparation of Heterocyclic Compound as Cholinergic Muscarinic M1 Receptor Positive Allosteric Modulator (M1PAM), Takeda Pharmaceutical Co. Ltd., Japan, 2020, p. 98.
E. T. van der Westhuizen, A. Spathis, E. Khajehali, M. Jörg, S. N. Mistry, B. Capuano, A. B. Tobin, P. M. Sexton, P. J. Scammells, C. Valant, A. Christopoulos, Mol. Pharmacol. 2018, 94, 770-783;
E. Khajehali, C. Valant, M. Jörg, A. B. Tobin, P. J. Conn, C. W. Lindsley, P. M. Sexton, P. J. Scammells, A. Christopoulos, Biochem. Pharmacol. 2018, 154, 243-254.
J. C. C. Dallagnol, E. Khajehali, E. T. van der Westhuizen, M. Jörg, C. Valant, A. G. Goncalves, B. Capuano, A. Christopoulos, P. J. Scammells, J. Med. Chem. 2018, 61, 2875-2894.
M. Jörg, E. T. van der Westhuizen, E. Khajehali, W. A. C. Burger, J. M. White, K. H. C. Choy, A. B. Tobin, P. M. Sexton, C. Valant, B. Capuano, A. Christopoulos, P. J. Scammells, ACS Chem. Neurosci. 2019, 10, 1099-1114.
L. T. May, K. Leach, P. M. Sexton, A. Christopoulos, Annu. Rev. Pharmacol. Toxicol. 2007, 47, 1-51.
K. Leach, P. M. Sexton, A. Christopoulos, Trends Pharmacol. Sci. 2007, 28, 382-389;
L. Aurelio, C. Valant, B. L. Flynn, P. M. Sexton, A. Christopoulos, P. J. Scammells, J. Med. Chem. 2009, 52, 4543-4547.
A. Christopoulos, Trends Pharmacol. Sci. 1998, 19, 351-357.
K. H. C. Choy, D. M. Shackleford, D. T. Malone, S. N. Mistry, R. T. Patil, P. J. Scammells, C. J. Langmead, C. Pantelis, P. M. Sexton, J. R. Lane, A. Christopoulos, J. Pharmacol. Exp. Ther. 2016, 359, 354-365.